KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Return on Assets: 2021-2025

Historic Return on Assets for Recursion Pharmaceuticals (RXRX) over the last 5 years, with Sep 2025 value amounting to -0.53%.

  • Recursion Pharmaceuticals' Return on Assets fell 3.00% to -0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.53%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.44% for FY2024, which is 4.00% up from last year.
  • Per Recursion Pharmaceuticals' latest filing, its Return on Assets stood at -0.53% for Q3 2025, which was down 6.38% from -0.50% recorded in Q2 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Return on Assets peaked at -0.21% during Q3 2021, and registered a low of -0.58% during Q1 2024.
  • Its 3-year average for Return on Assets is -0.48%, with a median of -0.50% in 2025.
  • Its Return on Assets has fluctuated over the past 5 years, first declined by 20bps in 2024, then increased by 17bps in 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Return on Assets (Quarterly) stood at -0.29% in 2021, then dropped by 9bps to -0.37% in 2022, then dropped by 14bps to -0.51% in 2023, then increased by 8bps to -0.43% in 2024, then decreased by 3bps to -0.53% in 2025.
  • Its last three reported values are -0.53% in Q3 2025, -0.50% for Q2 2025, and -0.42% during Q1 2025.